Per LDNScience.org,
“What Is LDN Being
Used For?”
Low Dose Naltrexone (LDN) is being
used as a regulator of
the immune system,
providing relief to
patients with autoimmune
diseases, and central nervous system
disorders. Whilst it is not
licensed by the FDA specifically for
these conditions, physicians
are permitted to prescribe LDN
‘off-label’ for treatments they
think are appropriate.
The apparently diverse conditions
in which LDN appears to
have a therapeutic effect are
united by their ability to benefit
from increased levels of endorphins
(naturally occurring opioids
– specifically OGF).
In the interests of promoting
further research into different
uses of LDN, we encourage LDN
users who are willing to
be identified to share their
experiences with LDN by clicking
on Submit Your Story.
Examples of the successful use
of LDN, supported by studies
as well as reported by patients
to date, include the following
conditions:
Click here to read more info
- Adenoid Cystic Carcinoma
- Autism Spectrum Disorder
- AutoImmune (general)
- Cancer (general)
- Cholangiocarcinoma
- Colon Cancer
- Constipation (chronic)
- Crohn’s Disease
- CRPS
- Diabetic Neuropathy
- Esophageal Carcinoma
- Fibromyalgia
- Hepatoblastoma
- IBD
- IBS
- Interstitial Cystitis
- Lung Cancer
- Lymphoma
- Mesenteric Panniculitis
- MS (Multiple Sclerosis)
- Ovarian Cancer
- Pain (chronic)
- Pancreatic Cancer
- Parotid Carcinoma
- Systemic Sclerosis
- Transverse Myelitis
- Ulcerative Colitis
- Uterine Sarcoma
- Allergies
- AutoImmune (general)
- Cancer (general)
- CFS
- Colitis
- Epstein-Barr
- Fibromyalgia
- Hashimoto’s
- Hepatitis C
- Hypertension
- Hypothyroidism
- Interstitial Cystitis
- Lung Cancer
- Lupus
- Lyme Disease
- MS (Multiple Sclerosis)
- Parkinson’s
- Raynaud’s
- Reactive Hypoglycemia
- Restless Leg Syndrome
- Rheumatoid Arthritis
- Sinusitis
- Sjogren’s
- Spondyloarthropathy
- Transverse Myelitis
- Ulcerative Colitis